---
title: "Nurix Therapeutics, Inc. Stock 12‑Month Price Target Raised to $32.87, Implies 42% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292982845.md"
description: "Nurix Therapeutics' 12-month average price target was raised to $32.87 by 15 analysts, up from $32.50, implying a 42% upside based on the July 16 closing price. The consensus rating remains 'Buy', with 14 analysts recommending Buy and one holding."
datetime: "2026-07-17T04:20:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292982845.md)
  - [en](https://longbridge.com/en/news/292982845.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292982845.md)
generator: "portal-rs"
---

# Nurix Therapeutics, Inc. Stock 12‑Month Price Target Raised to $32.87, Implies 42% Upside

-   According to estimates from 15 analysts, Nurix Therapeutics, Inc. stock's average price target has risen from $32.5 to $32.87, with forecasts ranging from $23 to $45 per share
-   Based on the Jul. 16 closing price, the updated target implies approximately 42% potential upside
-   Consensus rating remains at “Buy” across 15 covering analysts, with 14 Buys, 1 Holds and 0 Sells

Explore more price target data and ratings for Nurix Therapeutics, Inc. on the , and track all previous and future analyst recommendations for Nurix Therapeutics, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [NRIX.US](https://longbridge.com/en/quote/NRIX.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Edmond DE Rothschild Holding S.A. Invests $2.18 Million in Nurix Therapeutics, Inc. $NRIX](https://longbridge.com/en/news/296585941.md)
- [Nurix Therapeutics, Inc. Stock 12‑Month Price Target Raised to $32.5, Implies 32% Upside](https://longbridge.com/en/news/292361447.md)
- [Does Interparfums’ (IPAR) Earnings Upgrade Hint At Deeper Strength In Its Profit Model?](https://longbridge.com/en/news/296564505.md)
- [Starfighters Space, Inc. GAAP EPS of -$0.24](https://longbridge.com/en/news/296400745.md)
- [CONMED (CNMD) Could Be 8% Overvalued Following Its Recent Rebound](https://longbridge.com/en/news/296318744.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**